Characteristics of Induced Ventricular Fibrillation Cycle Length in Symptomatic Brugada Syndrome Patients

被引:3
|
作者
Hiratsuka, Atsushi [2 ]
Shimizu, Akihiko [1 ]
Ueyama, Takeshi [2 ]
Yoshiga, Yasuhiro [2 ]
Doi, Masahiro [2 ]
Ohmiya, Toshihide [2 ]
Yoshida, Masaaki [2 ]
Fukuda, Masakazu [2 ]
Matsuzaki, Masunori [2 ]
机构
[1] Yamaguchi Univ, Grad Sch Med, Fac Hlth Sci, Ube, Yamaguchi 7558505, Japan
[2] Yamaguchi Univ, Div Cardiol, Dept Med & Clin Sci, Grad Sch Med, Ube, Yamaguchi 7558505, Japan
关键词
Brugada syndrome; Electrophysiological stimulation; Fast-Fourier transformation analysis; Ventricular fibrillation; FOURIER-TRANSFORM ANALYSIS; ATRIAL-FIBRILLATION; SPECTRAL-ANALYSIS; OUTFLOW TRACT; DEFIBRILLATOR IMPLANTATION; HEART-DISEASE; SUDDEN-DEATH; FREQUENCY; HUMANS; LEADS;
D O I
10.1253/circj.CJ-11-1144
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Limited information is available on the ventricular fibrillation (VF) spectrum in Brugada syndrome (BS) patients. We clarified differences in the VF cycle length (CL) using fast-Fourier transformation (FFT) analysis in symptomatic and asymptomatic BS patients. Methods and Results: VF was induced by pacing from the right ventricular (RV) apex and/or RV outflow tract (RVOT) for >8s. A 4096-point FFT analysis of results from 28 male BS patients (51.1 +/- 13.7 years old) was performed. Dominant frequency (DF) from phases 1 (4s) to 6 was obtained at 2-s intervals. The average DF from surface and intracardiac electrograms (ECG: DFECG; ICE: DFICE,, respectively) was compared between symptomatic and asymptomatic patients. Symptomatic patients had a significantly shorter effective refractory period at a CL of 600 ms at the RVOT than asymptomatic patients. DFECG significantly increased with phase (5.64 +/- 0.32 Hz in phase 1 to 6.16 +/- 0.52 Hz in phase 6) and was significantly higher in symptomatic patients than in asymptomatic patients. DFECG had the same characteristics as DFECG. Conclusions: Induced VF in BS patients can be characterized using FFT analysis. Our data support the hypothesis that symptomatic patients have a significantly shorter VF CL than asymptomatic patients. (Circ J 2012; 76: 624-633)
引用
收藏
页码:624 / 633
页数:10
相关论文
共 50 条
  • [1] Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome
    Kanda, M
    Shimizu, W
    Matsuo, K
    Nagaya, N
    Taguchi, A
    Suyama, K
    Kurita, T
    Aihara, N
    Kamakura, S
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (11) : 1799 - 1805
  • [2] Different characteristics between spontaneous and induced ventricular fibrillation in patients with Brugada syndrome
    Mizumaki, Koichi
    Fujiki, Akira
    Nishida, Kunihiro
    Tsuneda, Takayuki
    Sakamoto, Tamotsu
    Iwamoto, Jotaro
    Inoue, Hioshi
    [J]. CIRCULATION, 2007, 116 (16) : 391 - 391
  • [3] Effects of verapamil on anterior ST segment and ventricular fibrillation cycle length in patients with Brugada syndrome
    Chinushi, Masaomi
    Iijima, Kenichi
    Tagawa, Minoru
    Komura, Satoru
    Furushima, Hiroshi
    Aizawa, Yoshifusa
    [J]. JOURNAL OF ELECTROCARDIOLOGY, 2009, 42 (04) : 367 - 373
  • [4] Unsuccessful internal defibrillation in Brugada syndrome: Focus on refractoriness and ventricular fibrillation cycle length
    Watanabe, H
    Chinushi, M
    Sugiura, H
    Washizuka, T
    Komura, S
    Hosaka, Y
    Furushima, H
    Watanabe, H
    Hayashi, J
    Aizawa, Y
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2005, 16 (03) : 262 - 266
  • [5] Cycle length characteristics differentiating non-sustained from self-terminating ventricular fibrillation in Brugada syndrome
    Cismaru, Gabriel
    Brembilla-Perrot, Beatrice
    Pauriah, Maheshwar
    Zinzius, Pierre Yves
    Sellal, Jean Marc
    Schwartz, Jerome
    Sadoul, Nicolas
    [J]. EUROPACE, 2013, 15 (09): : 1313 - 1318
  • [6] Risk stratification of ventricular fibrillation in patients with symptomatic Brugada syndrome using pharmacological tests
    Kawano, Kyoko
    Shinohara, Tetsuji
    Kondo, Hidekazu
    Ishii, Yumi
    Takahashi, Masaki
    Mitarai, Kazuki
    Hirota, Kei
    Fukui, Akira
    Akioka, Hidefumi
    Teshima, Yasushi
    Yufu, Kunio
    Nakagawa, Mikiko
    Takahashi, Naohiko
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2023, 34 (01) : 180 - 188
  • [7] Exercise-Induced Ventricular Fibrillation in Patients with Brugada Syndrome Phenotype
    Ueoka, Akira
    Morita, Hiroshi
    Mizuno, Tomofumi
    Masuda, Takuro
    Asada, Saori
    Miyamoto, Masakazu
    Kawada, Satoshi
    Nakagawa, Koji
    Nishii, Nobuhiro
    Nakamura, Kazufumi
    Ito, Hiroshi
    [J]. CIRCULATION, 2022, 146
  • [8] Alcohol-induced Ventricular Fibrillation in Brugada Syndrome
    Hayashi, Takekuni
    Mitani, Haruo
    Goto, Kosaku
    Ishimura, Rieko
    Tao, Susumu
    Ito, Sachiko
    Masuda, Jun
    Fujimoto, Hajime
    Fujimoto, Yo
    Ishiwata, Sugao
    Yamaguchi, Tetsu
    Ohno, Minoru
    [J]. JOURNAL OF ARRHYTHMIA, 2009, 25 (01) : 32 - 35
  • [9] Implication of induced ventricular fibrillation during electrophysiologic study in patients with Brugada syndrome
    Kanda, M
    Shimizu, W
    Matsuo, K
    Kurita, T
    Taguchi, A
    Suyama, K
    Aihara, N
    Kamakura, S
    [J]. CIRCULATION, 1999, 100 (18) : 582 - 582
  • [10] Efficacy of potassium channel blockers for induced ventricular fibrillation in patients with Brugada syndrome
    Tatsumoto, A.
    Mizusawa, Y.
    Nakai, M.
    Fukamizu, S.
    Sakurada, H.
    Nishizaki, M.
    Hiraoka, M.
    [J]. EUROPEAN HEART JOURNAL, 2008, 29 : 635 - 635